Skip to main content
main-content

Tipp

Weitere Artikel dieser Ausgabe durch Wischen aufrufen

Erschienen in: hautnah 2/2019

19.11.2018 | Herpesviren | Gürtelrose

Herpes zoster rasch erkennen und effizient behandeln

verfasst von: MD Prof. Dr. U. Wollina

Erschienen in: hautnah | Ausgabe 2/2019

Einloggen, um Zugang zu erhalten
share
TEILEN

Auszug

Folgen einer Primärinfektion mit Varizella-zoster-Virus (VZV), auch humanes Herpes-Virus 3 genannt, sind die Varizellen mit einem Erkrankungsgipfel zwischen dem dritten und fünften Lebensjahr. …
Literatur
1.
Zurück zum Zitat Jensen NJ, Rivailler P, Tseng HF, Quinlivan ML et al. Revisiting the genotyping scheme for varicella-zoster viruses based on whole-genome comparisons. J Gen Virol. 2017;98:1434–8 CrossRefPubMedPubMedCentral Jensen NJ, Rivailler P, Tseng HF, Quinlivan ML et al. Revisiting the genotyping scheme for varicella-zoster viruses based on whole-genome comparisons. J Gen Virol. 2017;98:1434–8 CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Weinberg A, Canniff J, Rouphael N, Mehta A et al. Varicella-zoster virus-specific cellular immune responses to the live attenuated zoster vaccine in young and older adults. J Immunol. 2017;199:604–12 CrossRefPubMedPubMedCentral Weinberg A, Canniff J, Rouphael N, Mehta A et al. Varicella-zoster virus-specific cellular immune responses to the live attenuated zoster vaccine in young and older adults. J Immunol. 2017;199:604–12 CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Kurapati S, Sadaoka T, Rajbhandari L, Jagdish B et al. Role of the JNK pathway in varicella-zoster virus lytic infection and reactivation. J Virol. 2017;91:pii:e00640–17 CrossRefPubMedPubMedCentral Kurapati S, Sadaoka T, Rajbhandari L, Jagdish B et al. Role of the JNK pathway in varicella-zoster virus lytic infection and reactivation. J Virol. 2017;91:pii:e00640–17 CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Silva JR, Lopes AH, Talbot J, Cecilio NT et al. Neuroimmune-glia interactions in the sensory ganglia account for the development of acute herpetic neuralgia. J Neurosci. 2017;37:6408–22 CrossRefPubMed Silva JR, Lopes AH, Talbot J, Cecilio NT et al. Neuroimmune-glia interactions in the sensory ganglia account for the development of acute herpetic neuralgia. J Neurosci. 2017;37:6408–22 CrossRefPubMed
5.
Zurück zum Zitat Wiese-Posselt M, Siedler A, Mankertz A, Sauerbrei A et al. Varicella-zoster virus seroprevalence in children and adolescents in the pre-varicella vaccine era, Germany. BMC Infect Dis. 2017;17:356 CrossRefPubMedPubMedCentral Wiese-Posselt M, Siedler A, Mankertz A, Sauerbrei A et al. Varicella-zoster virus seroprevalence in children and adolescents in the pre-varicella vaccine era, Germany. BMC Infect Dis. 2017;17:356 CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Pinchinat S, Cebrián-Cuenca AM, Bricout H, Johnson RW. Similar herpes zoster incidence across Europe: results from a systematic literature review. BMC Infect Dis. 2013;13:170 CrossRefPubMedPubMedCentral Pinchinat S, Cebrián-Cuenca AM, Bricout H, Johnson RW. Similar herpes zoster incidence across Europe: results from a systematic literature review. BMC Infect Dis. 2013;13:170 CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Hillebrand K, Bricout H, Schulze-Rath R, Schink T, Garbe E. Incidence of herpes zoster and its complications in Germany, 2005–2009. J Infect. 2015;70:178–86 CrossRefPubMed Hillebrand K, Bricout H, Schulze-Rath R, Schink T, Garbe E. Incidence of herpes zoster and its complications in Germany, 2005–2009. J Infect. 2015;70:178–86 CrossRefPubMed
9.
Zurück zum Zitat Hansson E, Forbes HJ, Langan SM, Smeeth L, Bhaskaran K. Herpes zoster risk after 21 specific cancers: population-based case-control study. Br J Cancer. 2017;116:1643–51 CrossRefPubMedPubMedCentral Hansson E, Forbes HJ, Langan SM, Smeeth L, Bhaskaran K. Herpes zoster risk after 21 specific cancers: population-based case-control study. Br J Cancer. 2017;116:1643–51 CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Osterman MT, Sandborn WJ, Colombel JF, Peyrin-Biroulet L et al. Crohn’s disease activity and concomitant immunosuppressants affect the risk of serious and opportunistic infections in patients treated with adalimumab. Am J Gastroenterol. 2016;111:1806–15 CrossRefPubMed Osterman MT, Sandborn WJ, Colombel JF, Peyrin-Biroulet L et al. Crohn’s disease activity and concomitant immunosuppressants affect the risk of serious and opportunistic infections in patients treated with adalimumab. Am J Gastroenterol. 2016;111:1806–15 CrossRefPubMed
11.
Zurück zum Zitat Winthrop KL, Yamanaka H, Valdez H, Mortensen E et al. Herpes zoster and tofacitinib therapy in patients with rheumatoid arthritis. Arthritis Rheumatol. 2014;66:2675–84 CrossRefPubMedPubMedCentral Winthrop KL, Yamanaka H, Valdez H, Mortensen E et al. Herpes zoster and tofacitinib therapy in patients with rheumatoid arthritis. Arthritis Rheumatol. 2014;66:2675–84 CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Adelzadeh L, Jourabchi N, Wu JJ. The risk of herpes zoster during biological therapy for psoriasis and other inflammatory conditions. J Eur Acad Dermatol Venereol. 2014;28:846–52 CrossRefPubMed Adelzadeh L, Jourabchi N, Wu JJ. The risk of herpes zoster during biological therapy for psoriasis and other inflammatory conditions. J Eur Acad Dermatol Venereol. 2014;28:846–52 CrossRefPubMed
13.
Zurück zum Zitat Schink T, Behr S, Thöne K, Bricout H, Garbe E. Risk of stroke after herpes zoster - evidence from a German self-controlled case-series study. PLoS One. 2016;11:e0166554 CrossRefPubMedPubMedCentral Schink T, Behr S, Thöne K, Bricout H, Garbe E. Risk of stroke after herpes zoster - evidence from a German self-controlled case-series study. PLoS One. 2016;11:e0166554 CrossRefPubMedPubMedCentral
14.
15.
Zurück zum Zitat Wollina U, Machetanz J. Herpes zoster and postzosterische Neuralgie. Hautarzt. 2016;67:653–65 CrossRefPubMed Wollina U, Machetanz J. Herpes zoster and postzosterische Neuralgie. Hautarzt. 2016;67:653–65 CrossRefPubMed
16.
Zurück zum Zitat Wilson DA, Yen-Lieberman B, Schindler S, Asamoto K et al. Should varicella-zoster virus culture be eliminated? A comparison of direct immunofluorescence antigen detection, culture, and PCR, with a historical review. J Clin Microbiol. 2012;50:4120–2 CrossRefPubMedPubMedCentral Wilson DA, Yen-Lieberman B, Schindler S, Asamoto K et al. Should varicella-zoster virus culture be eliminated? A comparison of direct immunofluorescence antigen detection, culture, and PCR, with a historical review. J Clin Microbiol. 2012;50:4120–2 CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Arruti M, Piñeiro LD, Salicio Y, Cilla G et al. Incidence of varicella zoster virus infections of the central nervous system in the elderly: a large tertiary hospital-based series (2007–2014). J Neurovirol. 2017;23:451–9 CrossRefPubMed Arruti M, Piñeiro LD, Salicio Y, Cilla G et al. Incidence of varicella zoster virus infections of the central nervous system in the elderly: a large tertiary hospital-based series (2007–2014). J Neurovirol. 2017;23:451–9 CrossRefPubMed
19.
Zurück zum Zitat Werner RN, Nikkels AF, Marinovic B, Schäfer M et al. European consensus-based (S2k) Guideline on the Management of Herpes Zoster - guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV), Part 1: Diagnosis. J Eur Acad Dermatol Venereol. 2017;31:9–19 CrossRefPubMed Werner RN, Nikkels AF, Marinovic B, Schäfer M et al. European consensus-based (S2k) Guideline on the Management of Herpes Zoster - guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV), Part 1: Diagnosis. J Eur Acad Dermatol Venereol. 2017;31:9–19 CrossRefPubMed
20.
21.
Zurück zum Zitat Werner RN, Nikkels AF, Marinovic B, Schäfer M et al. European consensus-based (S2k) Guideline on the Management of Herpes Zoster–guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV), Part 2: Treatment. J Eur Acad Dermatol Venereol. 2017;31:20–9 CrossRefPubMed Werner RN, Nikkels AF, Marinovic B, Schäfer M et al. European consensus-based (S2k) Guideline on the Management of Herpes Zoster–guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV), Part 2: Treatment. J Eur Acad Dermatol Venereol. 2017;31:20–9 CrossRefPubMed
22.
Zurück zum Zitat Wollina U. Herpes zoster. In: Katsambas A, Lotti T, Dessinioti C, D’Erme AM (Eds). European Handbook of Dermatological Treatments. 3rd Edition. Springer: Berlin Heidelberg 2015: pp. 379–84 CrossRef Wollina U. Herpes zoster. In: Katsambas A, Lotti T, Dessinioti C, D’Erme AM (Eds). European Handbook of Dermatological Treatments. 3rd Edition. Springer: Berlin Heidelberg 2015: pp. 379–84 CrossRef
23.
Zurück zum Zitat Weaver BA, Advisory Committee on Immunization Practices (ACIP) of the Centers for Disease Control and Prevention (2011) Update on the advisory committee on immunization practices’ recommendations for use of herpes zoster vaccine. J Am Osteopath Assoc 2011;111(Suppl 6):S31–S33 PubMed Weaver BA, Advisory Committee on Immunization Practices (ACIP) of the Centers for Disease Control and Prevention (2011) Update on the advisory committee on immunization practices’ recommendations for use of herpes zoster vaccine. J Am Osteopath Assoc 2011;111(Suppl 6):S31–S33 PubMed
24.
Zurück zum Zitat Le P, Sabella C, Rothberg MB. Preventing herpes zoster through vaccination: New developments. Cleve Clin J Med. 2017;84:359–66 CrossRefPubMed Le P, Sabella C, Rothberg MB. Preventing herpes zoster through vaccination: New developments. Cleve Clin J Med. 2017;84:359–66 CrossRefPubMed
25.
Zurück zum Zitat Lal H, Cunningham AL, Godeaux O et al. Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults. New Engl J Med. 2015;372:2087–96 CrossRefPubMed Lal H, Cunningham AL, Godeaux O et al. Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults. New Engl J Med. 2015;372:2087–96 CrossRefPubMed
26.
Zurück zum Zitat Cunningham AL, Lal H, Kovac M et al. Efficacy of the herpes zoster subunit vaccine in adults 70 years of age or older. New Engl J Med. 2016;375:1019–32 CrossRefPubMed Cunningham AL, Lal H, Kovac M et al. Efficacy of the herpes zoster subunit vaccine in adults 70 years of age or older. New Engl J Med. 2016;375:1019–32 CrossRefPubMed
27.
Zurück zum Zitat Blank PR, Ademi Z, Lu X, Szucs TD, Schwenkglenks M. Herpes zoster vaccine: A health economic evaluation for Switzerland. Hum Vaccin Immunother. 2017;13:1495–1504 CrossRefPubMedPubMedCentral Blank PR, Ademi Z, Lu X, Szucs TD, Schwenkglenks M. Herpes zoster vaccine: A health economic evaluation for Switzerland. Hum Vaccin Immunother. 2017;13:1495–1504 CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Hoshi SL, Kondo M, Okubo I. Cost-effectiveness of varicella vaccine against herpes zoster and post-herpetic neuralgia for elderly in Japan. Vaccine. 2017;35:3264–71 CrossRefPubMed Hoshi SL, Kondo M, Okubo I. Cost-effectiveness of varicella vaccine against herpes zoster and post-herpetic neuralgia for elderly in Japan. Vaccine. 2017;35:3264–71 CrossRefPubMed
29.
Zurück zum Zitat Sandherr M, Hentrich M, von Lilienfeld-Toal M, Massenkeil G et al. Antiviral prophylaxis in patients with solid tumours and haematological malignancies–update of the Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO). Ann Hematol. 2015;94:1441–50 CrossRefPubMedPubMedCentral Sandherr M, Hentrich M, von Lilienfeld-Toal M, Massenkeil G et al. Antiviral prophylaxis in patients with solid tumours and haematological malignancies–update of the Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO). Ann Hematol. 2015;94:1441–50 CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat Schröder C, Enders D, Schink T, Riedel O. Incidence of herpes zoster amongst adults varies by severity of immunosuppression. J Infect. 2017;75:207–15 CrossRefPubMed Schröder C, Enders D, Schink T, Riedel O. Incidence of herpes zoster amongst adults varies by severity of immunosuppression. J Infect. 2017;75:207–15 CrossRefPubMed
31.
Zurück zum Zitat Lin HC, Chao YH, Wu KH, Yen TY et al. Increased risk of herpes zoster in children with cancer: A nationwide population-based cohort study. Medicine (Baltimore). 2016;95:e4037 CrossRef Lin HC, Chao YH, Wu KH, Yen TY et al. Increased risk of herpes zoster in children with cancer: A nationwide population-based cohort study. Medicine (Baltimore). 2016;95:e4037 CrossRef
32.
Zurück zum Zitat Tsai SY, Chen HJ, Lio CF, Ho HP et al. Increased risk of herpes zoster in patients with psoriasis: A population-based retrospective cohort study. PLoS One. 2017;12:e0179447 CrossRefPubMedPubMedCentral Tsai SY, Chen HJ, Lio CF, Ho HP et al. Increased risk of herpes zoster in patients with psoriasis: A population-based retrospective cohort study. PLoS One. 2017;12:e0179447 CrossRefPubMedPubMedCentral
34.
Zurück zum Zitat Liao TL, Chen YM, Liu HJ, Chen DY. Risk and severity of herpes zoster in patients with rheumatoid arthritis receiving different immunosuppressive medications: a case-control study in Asia. BMJ Open. 2017;7:e014032 CrossRefPubMedPubMedCentral Liao TL, Chen YM, Liu HJ, Chen DY. Risk and severity of herpes zoster in patients with rheumatoid arthritis receiving different immunosuppressive medications: a case-control study in Asia. BMJ Open. 2017;7:e014032 CrossRefPubMedPubMedCentral
35.
36.
Zurück zum Zitat Schmidt SA, Mor A, Schùnheyder HC, Sùrensen HT et al. Herpes zoster as a marker of occult cancer: A systematic review and meta-analysis. J Infect. 2017;74:215–35 CrossRefPubMed Schmidt SA, Mor A, Schùnheyder HC, Sùrensen HT et al. Herpes zoster as a marker of occult cancer: A systematic review and meta-analysis. J Infect. 2017;74:215–35 CrossRefPubMed
37.
Zurück zum Zitat Lai SW, Lin CH, Lin HF, Lin CL et al. Herpes zoster correlates with increased risk of Parkinson’s disease in older people: A population-based cohort study in Taiwan. Medicine (Baltimore). 2017;96:e6075 CrossRef Lai SW, Lin CH, Lin HF, Lin CL et al. Herpes zoster correlates with increased risk of Parkinson’s disease in older people: A population-based cohort study in Taiwan. Medicine (Baltimore). 2017;96:e6075 CrossRef
38.
Zurück zum Zitat Lin TY, Yang FC, Lin CL, Kao CH et al. Herpes zoster infection increases the risk of peripheral arterial disease: A nationwide cohort study. Medicine (Baltimore). 2016;95:e4480 CrossRef Lin TY, Yang FC, Lin CL, Kao CH et al. Herpes zoster infection increases the risk of peripheral arterial disease: A nationwide cohort study. Medicine (Baltimore). 2016;95:e4480 CrossRef
Metadaten
Titel
Herpes zoster rasch erkennen und effizient behandeln
verfasst von
MD Prof. Dr. U. Wollina
Publikationsdatum
19.11.2018
Verlag
Springer Vienna
Erschienen in
hautnah / Ausgabe 2/2019
Print ISSN: 1866-2250
Elektronische ISSN: 2192-6484
DOI
https://doi.org/10.1007/s12326-018-0299-z